Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Metrics to compare | QSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −1.6x | −0.5x | |
PEG Ratio | −0.07 | −0.01 | 0.00 | |
Price / Book | 0.8x | 2.4x | 2.6x | |
Price / LTM Sales | 74.7x | 1.8x | 3.2x | |
Upside (Analyst Target) | 197.3% | 72.7% | 47.6% | |
Fair Value Upside | Unlock | 7.1% | 6.1% | Unlock |